Your browser doesn't support javascript.
loading
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial.
Chan, Stephen Lam; Chotipanich, Chanisa; Choo, Su Pin; Kwang, Su Wen; Mo, Frankie; Worakitsitisatorn, Akeanong; Tai, David; Sundar, Raghav; Ng, David Chee Eng; Loke, Kelvin Siu Hoong; Li, Leung; Ng, Kelvin Kwok Chai; Peng, Yong Wei; Yu, Simon Chun-Ho.
Afiliação
  • Chan SL; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chotipanich C; State Key Laboratory of Translational Oncology, Hong Kong SAR, China.
  • Choo SP; Hand-in-Hand Cancer Foundation, Hong Kong SAR, China.
  • Kwang SW; National Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Mo F; Curie Oncology and National Cancer Centre Singapore, Singapore, Singapore.
  • Worakitsitisatorn A; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore, Singapore.
  • Tai D; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Sundar R; Division of Intervention Radiology, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Ng DCE; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Loke KSH; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Li L; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Ng KKC; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, DUKE-NUS Singhealth, Singapore, Singapore.
  • Peng YW; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, DUKE-NUS Singhealth, Singapore, Singapore.
  • Yu SC; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Liver Cancer ; 11(5): 451-459, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36158588
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Liver Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Liver Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China